Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
screening pipeline, from stem-cell engineering to data analysis Develop and test improvements in single-cell methods and vector design Apply the technology in steady-state and disease settings Analyse
-
metabolism, cancer, regeneration and development. In this role, you will apply innovative computational approaches to analyze a broad range of single-cell and single-nucleus datasets, including RNA-seq, ATAC
-
students will have the opportunity to work together with internationally recognized scientists and develop their research projects in an innovative research environment. We also have a PhD Association, which
-
Application deadline: November 15, 2026 Innovative research focusing on the cross-talk between tumor cells and their microenvironment. The Department of Oncology, KU Leuven and the VIB Center
-
Application deadline: November 15, 2026 Innovative research focusing on the cross-talk between tumor and immune cells. The VIB Center for Cancer Biology (VIB CCB) and the Department of Oncology, KU
-
lasting impact on science, health, and society A competitive salary and benefits package Start date: as soon as possible How to Apply Please submit your application using the online form (https
-
their career in an entrepreneurial and innovative environment. About us VIB is a world-renowned life sciences research institute in Flanders, Belgium. With more than 2,000 scientists and staff across
-
, nanopores, and ion channels for in vitro bioelectronic applications. The project sits at the interface of protein design and applied technology: the successful candidate will learn and apply state-of-the-art
-
We are seeking a motivated and creative PhD student to develop the next generation of AI-driven protein design methods that explicitly account for protein–lipid and protein–membrane interactions
-
an excellent reputation in technology transfer. VIB Technologies constitutes the centralized scientific research infrastructure of the institute and allows scientists access to high-end and innovative